Life Sciences Ontario
Life Sciences Ontario (LSO) strives to be the unified Voice of Life Sciences in Ontario by representing the interests of the diverse life sciences community in the province through advocacy, education, facilitation of economic development and promotion of the industry locally, nationally and internationally. Together we are a strong, innovative sector with significant socioeconomic contributions to the province of Ontario. We hope you will consider joining LSO and help us to achieve our vision for Ontario's life sciences sector - "Diversity of Members, Unity of Voice".
PlantForm to receive Government of Canada funding to advance HIV antibody research
Wednesday, December 21, 2016
PlantForm Corporation is advancing its work on innovative antibody treatments for human immunodeficiency virus (HIV) with a financial contribution of up to $117,400 and technical and business advisory services from the National Research Council of Canada Industry Research Assistance Program (IRAP). It is the third round of funding PlantForm has received from IRAP for the HIV project since 2012, for a total financial contribution of up to $1,484,970.
Innovative Medicines Canada Welcomes Pamela Fralick as New President
Thursday, December 1, 2016
Innovative Medicines Canada is pleased to announce the appointment of Pamela Fralick as its new President, effective immediately.
Ms. Fralick comes to Innovative Medicines Canada as a proven healthcare leader, with a wealth of experience advancing critical healthcare initiatives and a deep understanding of public policy and organizational management.
Cyclica Receives the Healthcare and Life Sciences Award for Excellence in Life Saving Therapeutics 2016
Thursday, December 1, 2016
Cyclica, an in silico drug discovery company that offers a novel proteome-wide screening predictive analytics platform for the pharmaceutical and related industries, has been recognized by Corporate LiveWire Magazine in their 2016 Healthcare and Life Sciences Award series in the category of Excellence in Life Saving Therapeutics. The platform is being used and validated through third-party organizations to develop safer and more effective therapeutics. Whether hypothetical, pre-clinical, clinical, or FDA-approved, Cyclica offers proteome-wide insight and analysis into a small molecules effect augmenting drug discovery pipelines, and efficiently taking assets from bench-to-bedside.
Life Sciences Ontario announces 2017 LSO Awards honouring Ontario life science leaders
Wednesday, November 30, 2016
Life Sciences Ontario (LSO) today announced its 2017 LSO Award Winners, in recognition of outstanding contributions to the provinces life sciences sector. The awards will be presented at LSOs Annual Awards Gala on March 1, 2017 at Torontos Liberty Grand.
"This years LSO Award recipients represent the very best within our sector," says Paul Lucas, Chair of LSOs Board of Directors. "We are incredibly lucky to have this calibre of talent here in Ontario, and were pleased to be able to recognize these individuals and their contributions."
CETA opens new pathways for Canadian innovation -- now we need to build on it
Wednesday, November 2, 2016
It's been a long and bumpy road toward CETA. The much-anticipated Comprehensive Economic and Trade Agreement between Canada and the European Union was signed by Prime Minister Justin Trudeau on Sunday under provisional terms, bringing the majority of the deal into force.
The agreement continues provisions directly impacting Canada's life sciences sector and the protection of Canadian innovation, most notably: